| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yan Li, Yun-Feng Zhou, Han Liang, Hua-Qing Wang, Ji-Hui Hao, Zheng-Gang Zhu, De-Seng Wan, Lun-Xiu Qin, Shu-Zhong Cui, Jia-Fu Ji, Hui-Mian Xu, Shao-Zhong Wei, Hong-Bin Xu, Tao Suo, Shu-Jun Yang, Cong-Hua Xie, Xiao-Jun Yang and Guo-Liang Yang |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yan Li, MD, PhD, Department of Peritoneal Cancer Surgery, Cancer Center of Beijing Shijitan Hospital Affiliated to the Capital Medical University, No 10, Tieyi Road, Yangfangdian, Haidian District, Beijing 100038, China. liyansd2@163.com |
| Key Words |
Expert consensus; Peritoneal carcinomatosis; Cytoreductive surgery; Intraperitoneal hyperthermic chemotherapy; Gastric cancer; Colorectal cancer; Ovarian cancer; Peritoneal mesothelioma; Pseudomyxoma Peritonei; Peritoneal sarcoma |
| Core Tip |
Cytoreductive surgery (CRS) + hyperthermic intraperitoneal chemotherapy (HIPEC) has been considered as the standard treatment for selected patients with peritoneal carcinomatosis (PC) in many established cancer centers worldwide. This Chinese expert consensus summarizes the mechanism of CRS + HIPEC to treat PC and its clinical efficacy in gastric cancer, colorectal cancer, ovarian cancer, pseudomyxoma peritonei, malignant peritoneal mesothelioma, and peritoneal sarcoma. Furthermore, a clinical pathway of CRS + HIPEC to treat PC has also been formulated. |
| Publish Date |
2016-08-04 17:58 |
| Citation |
Li Y, Zhou YF, Liang H, Wang HQ, Hao JH, Zhu ZG, Wan DS, Qin LX, Cui SZ, Ji JF, Xu HM, Wei SZ, Xu HB, Suo T, Yang SJ, Xie CH, Yang XJ, Yang GL. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol 2016; 22(30): 6906-6916 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i30/6906.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i30.6906 |
